Company news

Connect Biopharma Holdings Limited news in 2026

Connect Biopharma Holdings Limited's news releases, calls and decks from 2026, newest first.

View company

Connect Biopharma Reports Third Quarter 2026 Financial Results and Provides Business Update

November 16, 2026

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation

September 30, 2026

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adult and Adolescent Participants with Asthma and Type 2 Inflammation

September 15, 2026

Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 3, 2026

Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update

August 12, 2026

Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma

June 17, 2026

Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference

May 12, 2026

Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026

Connect Biopharma Announces Enrollment in Phase 2 Seabreeze STAT Studies Will Continue as Planned Following Pre-Specified Interim Analysis

April 22, 2026

Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

March 30, 2026

Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD

March 29, 2026

Connect Biopharma Announces $20.2 Million Private Placement Financing

March 29, 2026

Results from Phase 3 Study of Rademikibart in Moderate-to-Severe Atopic Dermatitis to be Presented in the Late-Breaking Research Session at the 2026 American Academy of Dermatology (AAD) Annual Meeting

March 10, 2026

Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference

March 3, 2026

Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 19, 2026

Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026

January 11, 2026

Decks in 2026